LHX2 and esophageal squamous cell carcinoma: In vitro and in vivo functional experiments demonstrated that the knockdown of LHX2 significantly inhibited ESCC cells’ proliferation, tumor growth, migration, invasion, and metastasis, while the overexpression of LHX2 exerted the opposite effects.